• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [24038 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2012     NIHR Health Technology Assessment programme Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation
2012     NIHR Horizon Scanning Centre (NIHR HSC) Tolvaptan for autosomal dominant polycystic kidney disease
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Atorvastatin (Lipitor®) chewable tablets
2012     HAYES, Inc. Ganz trochanteric flip osteotomy approach to hip resurfacing for treatment of osteoarthritis
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Specialized services for people with alzheimer's disease]
2012     HAYES, Inc. Imageless computer-aided navigation for total knee arthroplasty
2012     NIHR Horizon Scanning Centre (NIHR HSC) Transportable haemodialysis machines for established renal failure
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Trastuzumab (Herceptin®)
2012     HAYES, Inc. Home-based cervical traction for treatment of neck pain
2012     HAYES, Inc. Intacs for the treatment of keratoconus
2012     NIHR Horizon Scanning Centre (NIHR HSC) Secukinumab for plaque psoriasis
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Linagliptin (Trajenta®)
2012     HAYES, Inc. Lifevest system (Asahi Kasei Corp.) wearable cardiac defibrillator for prevention of sudden cardiac arrest
2012     HAYES, Inc. Intravenous immunoglobulin for chronic inflammatory demyelinating polyneuropathy
2012     NIHR Health Technology Assessment programme The use of MElatonin in children with Neurodevelopmental Disorders and impaired Sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS)
2012     NIHR Horizon Scanning Centre (NIHR HSC) Brivanib alaninate for hepatocellular cancer
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Esomeprazole (Nexium® IV)
2012     HAYES, Inc. Minimally invasive lumbar decompression (mild; Vertos Medical Inc.) for lumbar spinal stenosis
2012     HAYES, Inc. Intravenous immunoglobulin for myasthenia gravis
2012     NIHR Horizon Scanning Centre (NIHR HSC) Cilengitide (Impetreve) for glioblastoma multiforme
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Adalimumab (Humira®)
2012     HAYES, Inc. Outpatient cervical traction for treatment of neck pain
2012     HAYES, Inc. Intravenous immunoglobulin for pulmonary diseases
2012     Health Information and Quality Authority (HIQA) Health technology assessment of robot-assisted surgery in Ireland
2012     NIHR Horizon Scanning Centre (NIHR HSC) Clofarabine (Evoltra) for acute myeloid leukaemia in older adults unsuitable for anthracycline-based combination chemotherapy
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Capsaicin 8% patch (Qutenza®)
2012     HAYES, Inc. Tearlab osmolarity system (TearLab Corp.) for diagnosis of dry eye disease
2012     NIHR Horizon Scanning Centre (NIHR HSC) Everolimus (Afinitor) in combination with trastuzumab and vinorelbine for HER2/neu positive, locally advanced or metastatic breast cancer
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Entecavir (Baraclude®)
2012     HAYES, Inc. Third eye retroscope (Avantis Medical Systems Inc.) for aiding the colonoscopic detection of colorectal polyps and adenomas
2012     NIHR Horizon Scanning Centre (NIHR HSC) Iniparib (Tivolza) in combination with gemcitabine and carboplatin for stage IV squamous non-small cell lung cancer
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Icatibant (Firazyr®)
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Belatacept (Nulojix®)
2012     Agency for Healthcare Research and Quality (AHRQ) Hematopoietic stem-cell transplantation in the pediatric population
2012     Malaysian Health Technology Assessment (MaHTAS) VNUS® Radiofrequency Ablation (RFA) for varicose vein
2012     NIHR Horizon Scanning Centre (NIHR HSC) Lapatinib in combination with capecitabine and oxaliplatin for advanced gastric, oesophageal or gastro-oesophageal cancer – first line
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Abiraterone (Zytiga®)
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Saxagliptin (Onglyza®)
2012     Agency for Healthcare Research and Quality (AHRQ) Noninvasive diagnostic tests for breast abnormalities: update of a 2006 review
2012     Penn Medicine Center for Evidence-based Practice (CEP) Post-discharge telephone calls to reduce hospital readmissions
2012     Malaysian Health Technology Assessment (MaHTAS) Vitamin C Injection for Cosmetic
2012     The Netherlands Organisation for Health Research and Development (ZonMw) [Inguinal hernia management: operation or observation? A randomised controlled multicenter trial]
2012     NIHR Horizon Scanning Centre (NIHR HSC) Lapatinib (Tyverb) in combination with trastuzumab for HER2-positive metastatic breast cancer – second line
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Emtricitabine/rilpivirine/tenofovir (Eviplera®)
2012     Agency for Healthcare Research and Quality (AHRQ) Adjuvant treatment for phenylketonuria (PKU)
2012     Penn Medicine Center for Evidence-based Practice (CEP) Systematic reviews of robot-assisted surgery: update
2012     NIHR Horizon Scanning Centre (NIHR HSC) Lapatinib (Tyverb) in combination with a taxane for HER2-positive metastatic breast cancer – first line
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Everolimus (Afinitor®)
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Paliperidone palmitate (Xeplion®) 50 mg, 75 mg, 100 mg and 150 mg prolonged release suspension for injection
2012     Agency for Healthcare Research and Quality (AHRQ) Fecal DNA testing in screening for colorectal cancer in average-risk adults
2012     Penn Medicine Center for Evidence-based Practice (CEP) Supplementary feedings for healthy breastfed full-term infants
2012     Malaysian Health Technology Assessment (MaHTAS) Titanium dioxide photocatalyst coatings
2012     NIHR Health Technology Assessment programme Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE)
2012     NIHR Horizon Scanning Centre (NIHR HSC) MDV-3100 for castration-resistant prostate cancer
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Dihydroartemisinin/piperaquine phosphate (Eurartesim®)
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Bupivacaine hydrochloride (1 mg/ml or 1.25 mg/ml) and fentanyl (2 micrograms/ml) solution for infusion (Bufyl®)
2012     Agency for Healthcare Research and Quality (AHRQ) Treatment for glaucoma: comparative effectiveness
2012     Penn Medicine Center for Evidence-based Practice (CEP) Composite indexes of provider performance
2012     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Surgical simulation for training: skills transfer to the operating room (update)
2012     NIHR Health Technology Assessment programme Dasatinib and nilotinib for imatinib-resistant or -intolerant chronic myeloid leukaemia: a systematic review and economic evaluation
2012     NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab (Arzerra) in combination with chlorambucil for chronic lymphocytic leukaemia – first line
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Darunavir (Prezista®)
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Colecalciferol (Fultium-D3®) 800 IU capsules
2012     Agency for Healthcare Research and Quality (AHRQ) Screening for glaucoma: comparative effectiveness
2012     Penn Medicine Center for Evidence-based Practice (CEP) Biliary drainage for chemotherapy patients
2012     Malaysian Health Technology Assessment (MaHTAS) Sippy Cup
2012     NIHR Horizon Scanning Centre (NIHR HSC) Cabozantinib for medullary thyroid cancer
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Dexmedetomidine (Dexdor®)
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Eslicarbazepine acetate (Zebinix®) 800 mg tablets
2012     Agency for Healthcare Research and Quality (AHRQ) Treatment for depression after unsatisfactory response to SSRIs
2012     Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for use of screening and preventive services
2012     Malaysian Health Technology Assessment (MaHTAS) Radiofrequency neurotomy of genicular nerve of both knees
2012     NIHR Horizon Scanning Centre (NIHR HSC) FENIX® Continence Restoration System for severe chronic faecal incontinence
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ramipril 2.5 mg/5 ml oral solution
2012     Agency for Healthcare Research and Quality (AHRQ) Noninvasive technologies for the diagnosis of coronary artery disease in women
2012     Penn Medicine Center for Evidence-based Practice (CEP) Reconciliation of data from differing electronic medical records
2012     NIHR Health Technology Assessment programme Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antisepticimpregnated urethral catheters (the CATHETER trial)
2012     Agency for Healthcare Research and Quality (AHRQ) Methods for insulin delivery and glucose monitoring: comparative effectiveness
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Mercaptopurine (Xaluprine®) 20 mg/ml oral suspension
2012     HAYES, Inc. In utero fetal surgery for congenital diaphragmatic hernia
2012     Penn Medicine Center for Evidence-based Practice (CEP) Comparative effectiveness of troponin tests for diagnosis of myocardial infarction
2012     Haute Autorite de sante (HAS) [Physiotherapeutic treatment of lymphoedema and shoulder stiffness after breast cancer treatment]
2012     NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: SpringTMS™ Total Migraine System
2012     Agency for Healthcare Research and Quality (AHRQ) Nonsurgical treatments for urinary incontinence in adult women: diagnosis and comparative effectiveness
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Trastuzumab (Herceptin®) 150 mg powder for concentrate for solution for infusion
2012     HAYES, Inc. In utero fetal surgery for myelomeningocele
2012     Blue Cross Blue Shield Association (BCBS) Special report: chronic noncancer pain—long-term opioid benefits and harms
2012     Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) Criteria for appropriate use of FDG-PET in malignant lymphoma: Hodgkin's lymphoma, aggressive non-Hodgkin's lymphoma
2012     Haute Autorite de sante (HAS) [Assessment of an epiretinal prosthesis and its implantation procedure]
2012     Malaysian Health Technology Assessment (MaHTAS) Point-Of-Care test for Chlamydia
2012     HAYES, Inc. Epidermal Growth Factor Receptor (EGFR) sequence variant analysis for predicting response to Non-Small Cell Lung Cancer (NSCLC) drug therapy
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sitagliptin (Januvia®) 25 and 50 mg tablets
2012     HAYES, Inc. Ketamine for mood disorders
2012     Blue Cross Blue Shield Association (BCBS) Bariatric surgery in patients with diabetes and body mass index less than 35 kg/m2
2012     NIHR Health Technology Assessment programme EOS 2D/3D X-ray imaging system: a systematic review and economic evaluation
2012     NIHR Horizon Scanning Centre (NIHR HSC) Bioresorbable stents for occlusive coronary artery disease
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Vildagliptin (Galvus®) 50 mg tablets
2012     HAYES, Inc. Laparoscopic sleeve gastrectomy for super obesity in adults
2012     Blue Cross Blue Shield Association (BCBS) Laparoscopic adjustable gastric banding in patients with body mass index less than 35 kg/m2 with weight-related comorbidity
2012     Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) Criteria for the appropriate use of positron emission tomography with FDG (FDG-PET) in head and neck cancer